Daiichi Sankyo to pay $39M to settle DOJ claims it paid kickbacks to docs

Japanese drugmaker Daiichi Sankyo will pay $39 million to state and federal health programs, and a whistleblower, to settle claims it paid doctors kickbacks to prescribe some of its drugs, Reuters reports. The settlement, the Justice Department said, stemmed from a whistleblower lawsuit filed by former Daiichi sales representative Kathy Fragoules. She will get $6.1 million of the settlement. The drugmaker was accused of enticing doctors with speaking fees and lavish dinners, sometimes to speak only to their own staffs, the government contended. Story

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.